Tenet reaffirmed its latest FY24 adjusted EBITDA outlook range included in its second quarter 2024 earnings release.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on THC:
- Tenet Healthcare price target raised to $175 from $145 at Wells Fargo
- Tenet Healthcare price target raised to $171 from $156 at Barclays
- Tenet Healthcare price target raised to $170 from $155 at Truist
- Tenet Healthcare price target raised to $175 from $130 at Raymond James
- Tenet Healthcare price target raised to $160 from $155 at Deutsche Bank